| Questcor Pharmaceuticals May Not Be Done On The Upside |  |
 |
 |
| Monday, 12 November 2007 | |
Questcor Pharmaceuticals Made A Nice Run On Monday, Tuesday May Show Follow Through(NAMC) – On Monday Questcor Pharmaceuticals Inc. (AMEX: QSC) reported great earnings for their 3rd quarter of $14.8 million and that is compared with $4 million for the same period a year ago. This pushed the stock passed its 52-week high of $1.89 to close at $1.92 up 61 cents or over 46% on over 7.5 million shares traded for the day.The Net Income that they reported for the quarter was 12 cents per share versus a loss of 3 cents per share for the same period a year ago. This is called growth. It would not be a shock at all if Questcor Pharmaceuticals, in this volatile market, moves above the $2.40 range in short order. Investors should actually have this one in their sights.Louis Victor NAMC Newswire Note:NAMC Worldwide provides Investment Banking consulting services to both publicly traded and privately held companies, everything from capital raising to mergers and acquisitions. Other areas of focus are Private Equity Capital Raising and Private Commodity Transactions. This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
|
